(S)-5-((6-methoxy-1-oxoisoindolin-2-yl)methyl)-5-(4-(trifluoromethyl)furo[3,2-c]pyridin-2-yl)imidazolidine-2,4-dione

ID: ALA4104084

PubChem CID: 70232814

Max Phase: Preclinical

Molecular Formula: C21H15F3N4O5

Molecular Weight: 460.37

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc2c(c1)C(=O)N(C[C@@]1(c3cc4c(C(F)(F)F)nccc4o3)NC(=O)NC1=O)C2

Standard InChI:  InChI=1S/C21H15F3N4O5/c1-32-11-3-2-10-8-28(17(29)12(10)6-11)9-20(18(30)26-19(31)27-20)15-7-13-14(33-15)4-5-25-16(13)21(22,23)24/h2-7H,8-9H2,1H3,(H2,26,27,30,31)/t20-/m0/s1

Standard InChI Key:  CHCOFDMLMLXFJJ-FQEVSTJZSA-N

Molfile:  

     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
    8.8075  -14.2802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4030  -14.9901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2200  -14.9854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3341  -15.7702    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1512  -15.7702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7426  -14.5113    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0839  -14.9935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6327  -15.6908    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.3095  -16.4367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4507  -15.7691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9929  -15.1577    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.6253  -16.5674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9217  -16.9783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9267  -17.7912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6346  -18.1942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3389  -17.7784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3304  -16.9668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0507  -18.1798    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.0590  -18.9969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6322  -16.4308    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3066  -14.7413    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6190  -14.1857    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4704  -13.5313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0689  -12.9791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7813  -13.3852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4872  -12.9714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4818  -12.1515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7647  -11.7473    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0617  -12.1635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3500  -11.7619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3420  -10.9447    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.6464  -12.1774    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.6395  -11.3499    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  3  2  1  0
  4  5  1  0
  5  2  1  0
  2  6  1  0
  6  7  1  0
  7  4  1  0
  3  8  1  0
  8  9  1  0
  9 13  1  0
 12 10  1  0
 10  8  1  0
 10 11  2  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 16 18  1  0
 18 19  1  0
  5 20  2  0
  7 21  2  0
  1 22  1  0
 22 25  1  0
 24 23  1  0
 23  1  2  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 29 30  1  0
 30 31  1  0
 30 32  1  0
 30 33  1  0
M  END

Associated Targets(Human)

ADAM17 Tchem ADAM17 (3550 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Blood (2950 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 460.37Molecular Weight (Monoisotopic): 460.0995AlogP: 2.55#Rotatable Bonds: 4
Polar Surface Area: 113.77Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.60CX Basic pKa: 0.34CX LogP: 1.38CX LogD: 1.35
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.58Np Likeness Score: -0.34

References

1. Tong L, Kim SH, Rosner K, Yu W, Shankar BB, Chen L, Li D, Dai C, Girijavallabhan V, Popovici-Muller J, Yang L, Zhou G, Kosinski A, Siddiqui MA, Shih NY, Guo Z, Orth P, Chen S, Lundell D, Niu X, Umland S, Kozlowski JA..  (2017)  Fused bi-heteroaryl substituted hydantoin compounds as TACE inhibitors.,  27  (14): [PMID:28558971] [10.1016/j.bmcl.2017.05.062]

Source